Sunday, April 22, 2018
 
 
FDA authorizes new use of test, first to identify the emerging pathogen Candida auris
SILVER SPRING, Md., April 20, 2018 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration authorized the first test to identify the emerging pathogen Candida auris (C. auris), which can cause serious infections in hospitalized patients.
 
AloeVeritas Along with PainSmarts and the GPOSO, Announce Initiation of Phase I Observational Study Evaluating AloeMD
AloeVeritas along with PainSmarts and GPOSO (Global Professional Observational Study Organization), Announce Initiation of Phase I Observational Study Evaluating AloeMD for the relief of pain without Opioids, Steroids, and NSAIDs.
 
University of Utah College of Science opens new Crocker Science Center
SALT LAKE CITY, April 20, 2018 /PRNewswire/ -- University of Utah President Ruth V. Watkins and College of Science Dean Henry S. White, along with Gary and Ann Crocker and Utah Governor
 
New Jersey Hernia Mesh Lawsuit Plaintiffs Seek Centralized Docket for Ethicon Multi-Layer Polypropylene Device Claims, Bernstein Liebhard LLP Reports
NEW YORK, April 20, 2018 /PRNewswire/ -- Plaintiffs who have filed hernia mesh lawsuits against Ethicon, Inc. in New Jersey Superior Court have
 
FCB Health and Area 23 Make History at the 2018 Manny Awards
NEW YORK, April 20, 2018 /PRNewswire/ -- The FCB Health Network won big at the 29th Annual Manny Awards last night, taking home six trophies, with agency Area 23 earning the night's top accolades: Agency of the Year (Category 1), Most Creative Agency and Most Admired Agency. The Manny Awards – sponsored by Med .....
 
Kenneth J. Kaminski, M.D., is recognized by Continental Who's Who
TYLER, Texas, April 20, 2018 /PRNewswire/ -- Kenneth J. Kaminski, M.D., is recognized by Continental Who's Who as a Pinnacle Lifetime Member in recognition of his contributions to the Medical field.               
 
Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer
INDIANAPOLIS, April 20, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in patients with locally advanced or unresectable or met.....
 



ENT Devices: Market Shares, Strategies, Analysis and Forecasts, Worldwide, 2018 to 2025

 
UCB's Commitment in Neurology
ATLANTA, April 20, 2018 /PRNewswire/ -- Today, we announced an exciting addition to UCB's epilepsy p.....
 
Super Model-Turned-Super Mogul Kathy Ireland Interviews Anpac Bio CEO For 'Worldwide Business with Kathy Ireland'
SACRAMENTO, Calif., April 20, 2018 /PRNewswire/ -- Chris Yu, Chief Executive Officer of international life sciences corporation
 


 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines